OPEN MIC NEXT IN HEALTH SERIES – Health Tech Investing: Boost or Bust? (EN)
Fortunately we are already fully booked on site.
Please use the possibility of online participation.
Thank you very much.
Building up on the success of the Open Mic Next in Health Series in 2021 and 2022, Switzerland Innovation Park Basel Area and DayOne – Healthcare Innovation bring forward an exciting concept to accelerate digital health transformation – from Basel to the world.
Currently, life sciences, healthcare, and digital health companies face complex challenges from market access to pricing pressure, patient engagement and satisfaction, research and development (R&D), merger and acquisition decisions. Are health tech innovators and investors interested in the same healthcare challenges?
In this episode of the Open Mic Next in Health Series, we will talk about the fundamental issues of the healthcare industry the investors focus on, technologies that have received special attention in the past years, what the health tech investing predictions are, and how life sciences and healthcare organisations could drive the future of health through venture and innovation opportunities.
Health Tech Investing: Boost or Bust?
LIVE from Novartis Pavillon in Basel
8 May 2023, 16:30 – 17:45 CEST on site* and online
* Apéro and location kindly sponsored by Novartis
Participation is free, however registration is required before 28.04.2023 (on site).
- Dr. Christoph Kausch, Managing Partner at MTIP
- Daniel Dillinger, Investment Manager at Redalpine
- Dr. med. Steffen Achenbach, Managing Director dRx Capital at Novartis Pharma AG
Door Opening & Registration
Welcome & Introduction
Host – Rahel Schneider, Switzerland Innovation Park Basel Area
Moderator – Anca del Rio, DayOne – Healthcare Innovation
Couch discussion with the key opinion leaders